(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that current evidence is insufficient for assessing the balance of harms and benefits of screening for elevated blood lead levels in asymptomatic children and pregnant women. These findings form the basis of a draft recommendation statement published online Oct. 30.
You may also like
Medical News Today: Bubonic plague: Third case reported in China
- November 20, 2019
This week, officials have receivedRead more
Families of youth with autism face big barriers to care, gaps in services
- November 19, 2019
New research at Case Western ReserveRead more